U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Barrett esophagus

MedGen UID:
2551
Concept ID:
C0004763
Disease or Syndrome
Synonyms: BARRETT METAPLASIA; Barrett's esophagus
SNOMED CT: Barrett esophagus (302914006); Barretts esophagus (302914006); Columnar-lined esophagus (302914006); Gastric metaplasia of esophagus (302914006); Barrett's syndrome (302914006); Barrett's esophagus (302914006); CELLO - Columnar epithelial-lined lower esophagus (302914006); CLE - Columnar-lined esophagus (302914006); Columnar epithelial-lined lower esophagus (302914006)
 
Genes (locations): ASCC1 (10q22.1); CTHRC1 (8q22.3); MSR1 (8p22)
 
HPO: HP:0100580
Monarch Initiative: MONDO:0013662
OMIM®: 614266
Orphanet: ORPHA1232

Definition

Barrett esophagus, or Barrett metaplasia, describes the phenotypic change of normal esophageal squamous epithelium to a columnar and intestinal-type epithelium. This metaplastic change is important because patients with Barrett esophagus have an increased risk of esophageal adenocarcinoma. The main cause of Barrett metaplasia is gastroesophageal reflux (GER; 109350). The retrograde movement of acid and bile salts from the stomach into the esophagus in this disease causes prolonged injury to the esophageal epithelium and induces chronic esophagitis, which in turn is believed to trigger the pathologic changes (summary by Wong et al., 2005). [from OMIM]

Clinical features

From HPO
Barrett esophagus
MedGen UID:
2551
Concept ID:
C0004763
Disease or Syndrome
Barrett esophagus, or Barrett metaplasia, describes the phenotypic change of normal esophageal squamous epithelium to a columnar and intestinal-type epithelium. This metaplastic change is important because patients with Barrett esophagus have an increased risk of esophageal adenocarcinoma. The main cause of Barrett metaplasia is gastroesophageal reflux (GER; 109350). The retrograde movement of acid and bile salts from the stomach into the esophagus in this disease causes prolonged injury to the esophageal epithelium and induces chronic esophagitis, which in turn is believed to trigger the pathologic changes (summary by Wong et al., 2005).
Esophageal carcinoma
MedGen UID:
56256
Concept ID:
C0152018
Neoplastic Process
The presence of a carcinoma of the esophagus.
Gastroesophageal reflux
MedGen UID:
1368658
Concept ID:
C4317146
Finding
A condition in which the stomach contents leak backwards from the stomach into the esophagus through the lower esophageal sphincter.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVBarrett esophagus
Follow this link to review classifications for Barrett esophagus in Orphanet.

Conditions with this feature

Barrett esophagus
MedGen UID:
2551
Concept ID:
C0004763
Disease or Syndrome
Barrett esophagus, or Barrett metaplasia, describes the phenotypic change of normal esophageal squamous epithelium to a columnar and intestinal-type epithelium. This metaplastic change is important because patients with Barrett esophagus have an increased risk of esophageal adenocarcinoma. The main cause of Barrett metaplasia is gastroesophageal reflux (GER; 109350). The retrograde movement of acid and bile salts from the stomach into the esophagus in this disease causes prolonged injury to the esophageal epithelium and induces chronic esophagitis, which in turn is believed to trigger the pathologic changes (summary by Wong et al., 2005).
Gastroesophageal reflux disease
MedGen UID:
6553
Concept ID:
C0017168
Disease or Syndrome
Gastroesophageal reflux (GER) is characterized by the retrograde movement of stomach contents into the esophagus. In its most severe form, GER results in extensive tissue damage caused by acid reflux. In adolescents and adults, and even infrequently in children, chronic GER is associated with the risk of developing Barrett metaplasia (614266), a premalignant lesion of the esophageal mucosa (Hu et al., 2000). In turn, Barrett metaplasia is correlated with the development of adenocarcinoma of the esophagus (see 614266), estimated as the fifth most prevalent neoplasia in the Western world (Lagergren et al., 1999).
Mungan syndrome
MedGen UID:
369554
Concept ID:
C1969653
Disease or Syndrome
Visceral myopathy 2
MedGen UID:
1783630
Concept ID:
C5543466
Disease or Syndrome
Visceral myopathy-2 (VSCM2) is characterized by gastrointestinal symptoms resulting from intestinal dysmotility and paresis, including abdominal distention, pain, nausea, and vomiting. Some patients exhibit predominantly esophageal symptoms, with hiatal hernia and severe reflux resulting in esophagitis and stricture, whereas others experience chronic intestinal pseudoobstruction. Bladder involvement resulting in megacystis and megaureter has also been observed and may be evident at birth (Dong et al., 2019; Gilbert et al. (2020)).

Professional guidelines

Recent clinical studies

Etiology

Sharma P
JAMA 2022 Aug 16;328(7):663-671. doi: 10.1001/jama.2022.13298. PMID: 35972481
Iyer PG, Kaul V
Mayo Clin Proc 2019 Sep;94(9):1888-1901. doi: 10.1016/j.mayocp.2019.01.032. PMID: 31486383
Bujanda DE, Hachem C
Mo Med 2018 May-Jun;115(3):211-213. PMID: 30228724Free PMC Article
Kellerman R, Kintanar T
Prim Care 2017 Dec;44(4):561-573. Epub 2017 Oct 5 doi: 10.1016/j.pop.2017.07.001. PMID: 29132520
Chang P, Friedenberg F
Gastroenterol Clin North Am 2014 Mar;43(1):161-73. Epub 2013 Dec 27 doi: 10.1016/j.gtc.2013.11.009. PMID: 24503366Free PMC Article

Diagnosis

Sharma P
JAMA 2022 Aug 16;328(7):663-671. doi: 10.1001/jama.2022.13298. PMID: 35972481
Iyer PG, Kaul V
Mayo Clin Proc 2019 Sep;94(9):1888-1901. doi: 10.1016/j.mayocp.2019.01.032. PMID: 31486383
Bujanda DE, Hachem C
Mo Med 2018 May-Jun;115(3):211-213. PMID: 30228724Free PMC Article
Kellerman R, Kintanar T
Prim Care 2017 Dec;44(4):561-573. Epub 2017 Oct 5 doi: 10.1016/j.pop.2017.07.001. PMID: 29132520
Eluri S, Shaheen NJ
Gastrointest Endosc 2017 May;85(5):889-903. Epub 2017 Jan 18 doi: 10.1016/j.gie.2017.01.007. PMID: 28109913Free PMC Article

Therapy

Sharma P
JAMA 2022 Aug 16;328(7):663-671. doi: 10.1001/jama.2022.13298. PMID: 35972481
Rees JR, Lao-Sirieix P, Wong A, Fitzgerald RC
Cochrane Database Syst Rev 2021 Mar 4;3(3):CD004060. doi: 10.1002/14651858.CD004060.pub3. PMID: 33661543Free PMC Article
di Pietro M, Canto MI, Fitzgerald RC
Gastroenterology 2018 Jan;154(2):421-436. Epub 2017 Aug 2 doi: 10.1053/j.gastro.2017.07.041. PMID: 28778650Free PMC Article
Kellerman R, Kintanar T
Prim Care 2017 Dec;44(4):561-573. Epub 2017 Oct 5 doi: 10.1016/j.pop.2017.07.001. PMID: 29132520
Spechler SJ, Souza RF
N Engl J Med 2014 Aug 28;371(9):836-45. doi: 10.1056/NEJMra1314704. PMID: 25162890

Prognosis

Thrift AP
Nat Rev Gastroenterol Hepatol 2021 Jun;18(6):432-443. Epub 2021 Feb 18 doi: 10.1038/s41575-021-00419-3. PMID: 33603224
Iyer PG, Kaul V
Mayo Clin Proc 2019 Sep;94(9):1888-1901. doi: 10.1016/j.mayocp.2019.01.032. PMID: 31486383
Bollschweiler E, Plum P, Mönig SP, Hölscher AH
Expert Opin Pharmacother 2017 Jul;18(10):1001-1010. Epub 2017 Jun 7 doi: 10.1080/14656566.2017.1334764. PMID: 28540761
Splittgerber M, Velanovich V
Surg Clin North Am 2015 Jun;95(3):593-604. doi: 10.1016/j.suc.2015.02.011. PMID: 25965132
Chang P, Friedenberg F
Gastroenterol Clin North Am 2014 Mar;43(1):161-73. Epub 2013 Dec 27 doi: 10.1016/j.gtc.2013.11.009. PMID: 24503366Free PMC Article

Clinical prediction guides

Sharma P
JAMA 2022 Aug 16;328(7):663-671. doi: 10.1001/jama.2022.13298. PMID: 35972481
Kröner PT, Engels MM, Glicksberg BS, Johnson KW, Mzaik O, van Hooft JE, Wallace MB, El-Serag HB, Krittanawong C
World J Gastroenterol 2021 Oct 28;27(40):6794-6824. doi: 10.3748/wjg.v27.i40.6794. PMID: 34790008Free PMC Article
Montgomery E, Arnold CA, Lam-Himlin D, Salimian K, Waters K
Ann Diagn Pathol 2018 Dec;37:75-82. Epub 2018 Sep 28 doi: 10.1016/j.anndiagpath.2018.09.013. PMID: 30312881
Gaddam S
Dis Esophagus 2018 Mar 1;31(3) doi: 10.1093/dote/dox147. PMID: 29346553
Gupta M, Iyer PG
Gastroenterol Clin North Am 2015 Jun;44(2):265-83. doi: 10.1016/j.gtc.2015.02.003. PMID: 26021194

Recent systematic reviews

Rees JR, Lao-Sirieix P, Wong A, Fitzgerald RC
Cochrane Database Syst Rev 2021 Mar 4;3(3):CD004060. doi: 10.1002/14651858.CD004060.pub3. PMID: 33661543Free PMC Article
Schlottmann F, Dreifuss NH, Patti MG
Expert Rev Gastroenterol Hepatol 2020 Jun;14(6):425-433. Epub 2020 May 22 doi: 10.1080/17474124.2020.1764348. PMID: 32441160
Yeung KTD, Penney N, Ashrafian L, Darzi A, Ashrafian H
Ann Surg 2020 Feb;271(2):257-265. doi: 10.1097/SLA.0000000000003275. PMID: 30921053
Erőss B, Farkas N, Vincze Á, Tinusz B, Szapáry L, Garami A, Balaskó M, Sarlós P, Czopf L, Alizadeh H, Rakonczay Z Jr, Habon T, Hegyi P
Helicobacter 2018 Aug;23(4):e12504. Epub 2018 Jun 25 doi: 10.1111/hel.12504. PMID: 29938864Free PMC Article
Higuera-de-la-Tijera F
Medwave 2018 Mar 14;18(2):e7179. doi: 10.5867/medwave.2018.02.7179. PMID: 29547594

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NCCN, 2023
      NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Esophageal and Esophagogastric Junction Cancers, 2023
    • NICE, 2023
      UK NICE Guidance, NICE Guideline NG231, Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management, 2023
    • NICE, 2019
      UK NICE Clinical Guideline CG184, Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management, 2019

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...